Press release
Jul 20, 2023

Investor and Press Conference on Today’s Announcement Regarding the Acquisition and License Transaction with Idorsia

Tokyo, Japan and Cambridge, UK, 20 July 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), will hold an investor and press conference on today’s announcement; “Sosei Heptares Acquires Idorsia’s Pharmaceuticals Business in Japan and APAC (ex-China), Accelerating its Transformation into a Fully Integrated Biopharmaceutical Company.”


The conference will be held in person in Tokyo and virtually at 5pm JST (9am BST) on Thursday 20 July in Tokyo. The meeting is open to all existing and potential investors, sell-/buy-side analysts, and journalists and will consist of a presentation followed by a Q&A session. Please click here to pre-register, which will provide a link to access the webinar. Simultaneous Japanese/English translation will be provided.


Presentation slides will be made available through the investor section of the Company’s Home Page here. Archive streaming will be available here on the Company’s website after the event.